CAS: 780757-88-2 - (6S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-8-(naphthalen-1-ylmethyl)-4,7-dioxohexahydro-2H-pyrazino[1,2-a]pyrimidine-1(6H)-carboxamide
Formula:C33H32N4O4
InChI:InChI=1/C33H32N4O4/c38-27-15-13-23(14-16-27)19-29-32(40)35(21-26-11-6-10-25-9-4-5-12-28(25)26)22-30-36(18-17-31(39)37(29)30)33(41)34-20-24-7-2-1-3-8-24/h1-16,29-30,38H,17-22H2,(H,34,41)/t29-,30+/m0/s1
2H-PYRAZINO[1,2-A]PYRIMIDINE-1(6H)-CARBOXAMIDE,HEXAHYDRO-6-[(4-HYDROXYPHENYL)METHYL]-8-(1-NAPHTHALENYLMETHYL)-4,7-DIOXO-N-(PHENYLMETHYL)-,(6R,9AR)-REL-
CAS:780757-88-2
Formula:
C33H32N4O4
Purity:
99%
Color and Shape:
Solid
Molecular weight:
548.6316
Ref: IN-DA00G3IH
25mg | 171.00 € | ||
50mg | 271.00 € | ||
100mg | 574.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
ICG-001
CAS:780757-88-2
ICG001 is a β-catenin/TCF-mediated transcription inhibitor that selectively blocks β-catenin/CBP interaction.Cost-effective and quality-assured.
Formula:
C33H32N4O4
Purity:
99.55% - 99.7%
Color and Shape:
Solid
Molecular weight:
548.63
Ref: TM-T6113
1mg | 35.00 € | ||
5mg | 69.00 € | ||
10mg | 104.00 € | ||
25mg | 203.00 € | ||
50mg | 353.00 € | ||
100mg | 547.00 € | ||
500mg | 1,173.00 € | ||
1mL*10mM (DMSO) | 85.00 € |
Estimated delivery in United States, on Friday 24 Jan 2025
ICG 001
CAS:780757-88-2
Inhibits interaction between CREB binding protein (CBP) and Wnt/β-catenin
Formula:
C33H32N4O4
Purity:
Min. 95%
Molecular weight:
548.63 g/mol
Ref: 3D-FI24532
10mg | 194.00 € | ||
25mg | 310.00 € | ||
50mg | 436.00 € | ||
100mg | 646.00 € | ||
250mg | 996.00 € |
Estimated delivery in United States, on Friday 31 Jan 2025